- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05882955
Designing a Mixed-initiative Recipe Recommender App for Vegan and Vegetarian Sub-groups (PERNUG)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Iron is present in plant and animal-derived foods but the fractional absorption of iron from plant foods (that is the percent of iron absorbed from a consumed quantity) is often low (approx 10%) compared to iron from animal sources 25%-30%. It is therefore more challenging for vegans and vegetarians to achieve the Reference Nutrient Intake (RNI) for iron (8.7 mg/day for men over 18 and women over 50, 14.8 mg/day for women aged 18-50), and they are likely to absorb less of that iron and therefore are more likely to become iron depleted.
Plants do not synthesise vitamin B12 and unless fortified, plant-derived foods and beverages do not contain any vitamin B12. the RNI for vitamin B12 in the UK is 1.5 µg/day, therefore it is crucial that vegans and vegetarians take B12 supplements if they don't consume B12-fortified foods or find other ways of incorporating this vitamin into their diets.
Over a period of 17 weeks, participants will be asked to consume plants from the unit by following the recipes recommended by the app. The participants will then observe changes in their iron and vitamin B12 levels by following up with their GP and report the outcomes back to the researchers at three points during the study (week 0, week 6, and week 17). In addition, the participants will evaluate the usability of the app and the recipes recommended by the app.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgium, 3001
- Departement Computerwetenschappen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria
- Healthy menstruating female with regular menstruation cycle over 18 years old.
- Has been vegan, vegetarian or other diets that do not include the consumption of meat and fish for at least 1 year.
- Willing to remain on a plant-based diet for the duration of the study.
- Body Mass Index (BMI) between 18.5 - 40 kg/m2.
- Lives in Belgium.
- Willing to maintain a hydroponic unit at home and consume plants grown in the hydroponic unit (e.g., parsley, rocket, mizuna).
- Access to a smartphone or online platform as well as access to the internet.
Exclusion Criteria
- Those who have known allergies to the hydroponically grown salad greens (parsley, rocket, mizuna).
- Pescatarian (consumes fish and seafood) and flexitarian (consumes meat intermittently) vegetarian.
- Those with abnormal menstruation cycle time periods, <21 and >40-day
- BMI < 18.5 kg/m2 (underweight) and > 40 kg/m2 (severely obese).
- Those diagnosed or undergoing treatment for anaemia.
- Currently pregnant or lactating.
- Diagnosed medical conditions that may impact the study outcomes will be considered on an individual basis.
- On a, or about to start, a diet programme such as the 5:2 programme (5:2 programme is where an individual would eat normally for five days a week, and fast for two days a week by reducing calorie consumption).
- Unable to give written or verbal informed consent.
- Participating in another dietary intervention study nor given blood in another dietary study in the last 3 months.
- Any person related to or living with any member of the study team.
- Those who are part of the Line Manager/supervisory structure of the Chief Investigator.
- Those who have been asked to self-isolate or have been diagnosed with COVID-19 in the last 14 days. However, participants can be rescreened 7 days after the isolation period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dietary app 1
Dietary app recommends high iron or iron focused recipes
|
Participants will grow vitamin B12 biofortified plants for 17 weeks and consume (10 grams) of plant material for 11 weeks.
Participants will eat one or two recipes a day for 17 weeks
|
Sham Comparator: Dietary app 2
Dietary app recommends standard iron recipes
|
Participants will grow vitamin B12 biofortified plants for 17 weeks and consume (10 grams) of plant material for 11 weeks.
Participants will eat one or two recipes a day for 17 weeks
|
Experimental: Hydroponic unit 1
Growing vitamin B12 biofortified plants in a hydroponic unit
|
Participants will grow vitamin B12 biofortified plants for 17 weeks and consume (10 grams) of plant material for 11 weeks.
Participants will eat one or two recipes a day for 17 weeks
|
No Intervention: Hydroponic unit 2
No hydroponic unit given to participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in serum ferritin after the dietary app intervention
Time Frame: Week: 0, 6/7 and 17
|
Comparison of serum ferritin at baseline and after the intervention
|
Week: 0, 6/7 and 17
|
Change of serum B12 after the hydroponic unit intervention
Time Frame: Week: 6/7 and 17
|
Comparison of serum B12 at baseline and after the intervention
|
Week: 6/7 and 17
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
App usability rating
Time Frame: Week: 6/7 and 17
|
The usability of the mobile application will be scored on 100 using the System Usability Scale
|
Week: 6/7 and 17
|
Score on the Unified Theory of Acceptance and Use of Technology questionnaire
Time Frame: Week: 6/7 and 17
|
The acceptance of the mobile application will be measured using the Unified Theory of Acceptance and Use of Technology questionnaire on a scale of 1 to 5.
|
Week: 6/7 and 17
|
Recipe recommendation performance
Time Frame: Week: 17
|
The performance of the recipe recommendation system will be measured using the RESQUE questionnaire on a scale of 1 to 5.
|
Week: 17
|
Collaborators and Investigators
Investigators
- Principal Investigator: Katrien Verbert, KU Leuven
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- G-2021-4203-R5(AMD)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mobile Applications
-
University Grenoble AlpsCompletedMobile Applications | Mobile HealthFrance
-
National University of MalaysiaCompletedMobile ApplicationsMalaysia
-
Vicente Lorenzo-Zúñiga GarcíaCompletedMobile Applications | Cathartics
-
Istanbul University - Cerrahpasa (IUC)RecruitingCancer | Mobile Applications | Chemotherapeutic ToxicityTurkey
-
Universitair Ziekenhuis BrusselUnknown
-
University of TorontoUnknownMobile Applications | Diet, Healthy | Behavior, HealthCanada
-
University of California, Los AngelesCompletedContraception | Mobile Applications | Contraception BehaviorUnited States
-
Washington University School of MedicineMallinckrodtCompletedHealthy Volunteers | Mobile Applications | Feasibility StudyUnited States
-
Gazi UniversityCompletedPregnant Women | Mobile Applications | Adaptation | Postpartum PeriodTurkey
-
Texas A&M UniversityDriscoll Children's Hospital; Global Institute for Hispanic HealthRecruitingPregnant Women | Mobile Applications | Prenatal Care | Genetic TestingUnited States
Clinical Trials on Hydroponic unit
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustEnrolling by invitationIron Deficiency (Without Anemia) | B12 Deficiency VitaminUnited Kingdom
-
Ostfold Hospital TrustUniversity of TromsoCompletedLow Risk Birth; Births With Low Risk FactorNorway
-
Liberating Technologies, Inc.Vivonics, Inc.CompletedLower Limb Amputation Below Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation StumpUnited States
-
EuroPharma, Inc.Completed
-
Mayo ClinicCompletedPostoperative PainUnited States
-
Centre Hospitalier St AnneAssistance Publique - Hôpitaux de Paris; Ministry of Health, FranceRecruiting
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
Universidad de LeónActive, not recruiting
-
CRISPR Therapeutics AGViaCyteCompletedGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic DiseaseCanada
-
Catholic University of the Sacred HeartCompletedFood Hypersensitivity | Food Allergy | Nickel SensitivityItaly